ACM
JNJ icon

AlphaCrest Capital Management’s Johnson & Johnson JNJ Stock Holding History

AlphaCrest Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,205
Closed -$2.96M – 1082
2019
Q1 		$2.96M Buy
21,205
+8,424
+66% +$1.13M 0.45% 27
2018
Q4 		$1.65M Buy
+12,781
New +$1.78M 0.49% 14

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AlphaCrest Capital Management's JNJ Position: Q2 2019 in Review

AlphaCrest Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2019, closing a stake of 21,205 shares — an estimated $2.96M sold.

AlphaCrest Capital Management first reported a position in JNJ in Q4 2018 and held it in 2 quarters. The position peaked at $2.96M in Q1 2019. 2,756 funds tracked by Wall St. Rank hold JNJ as of Q2 2019.

  • AlphaCrest Capital Management reported no remaining Johnson & Johnson position as of Q2 2019 after selling out during the quarter.
  • AlphaCrest Capital Management sold 21,205 Johnson & Johnson shares in Q2 2019, an estimated $2.96M.
  • AlphaCrest Capital Management first reported a position in Johnson & Johnson in Q4 2018 and held it in 2 quarters.
  • AlphaCrest Capital Management's Johnson & Johnson position peaked at $2.96M in Q1 2019.
  • 2,756 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2019.

Based on AlphaCrest Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.